- Home
- SMLR vs VYGR Comparison
SMLR vs VYGR Comparison
Compare SMLR & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMLR
- VYGR
- Stock Information
- Founded
- SMLR 2007
- VYGR 2013
- Country
- SMLR United States
- VYGR United States
- Employees
- SMLR N/A
- VYGR N/A
- Industry
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- SMLR Health Care
- VYGR Health Care
- Exchange
- SMLR Nasdaq
- VYGR Nasdaq
- Market Cap
- SMLR 289.5M
- VYGR 309.7M
- IPO Year
- SMLR 2014
- VYGR 2015
- Fundamental
- Price
- SMLR $57.02
- VYGR $6.86
- Analyst Decision
- SMLR
- VYGR Strong Buy
- Analyst Count
- SMLR 0
- VYGR 8
- Target Price
- SMLR N/A
- VYGR $17.00
- AVG Volume (30 Days)
- SMLR 1.0M
- VYGR 591.6K
- Earning Date
- SMLR 11-04-2024
- VYGR 11-12-2024
- Dividend Yield
- SMLR N/A
- VYGR N/A
- EPS Growth
- SMLR N/A
- VYGR N/A
- EPS
- SMLR 2.04
- VYGR 0.47
- Revenue
- SMLR $58,938,000.00
- VYGR $163,784,000.00
- Revenue This Year
- SMLR N/A
- VYGR N/A
- Revenue Next Year
- SMLR N/A
- VYGR N/A
- P/E Ratio
- SMLR $27.98
- VYGR $14.71
- Revenue Growth
- SMLR N/A
- VYGR 3.40
- 52 Week Low
- SMLR $20.88
- VYGR $5.19
- 52 Week High
- SMLR $79.45
- VYGR $11.72
- Technical
- Relative Strength Index (RSI)
- SMLR 60.19
- VYGR 58.49
- Support Level
- SMLR $52.00
- VYGR $5.54
- Resistance Level
- SMLR $63.29
- VYGR $5.92
- Average True Range (ATR)
- SMLR 9.23
- VYGR 0.39
- MACD
- SMLR 0.41
- VYGR 0.04
- Stochastic Oscillator
- SMLR 38.18
- VYGR 74.55
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.